Literature DB >> 87461

Neoantigen of the complement membrane attack complex of cytotoxic human peripheral blood lymphocytes.

J S Sundsmo, H J Müller-Eberhard.   

Abstract

Neoantigenic determinants (neoAg) specific for the assembling membrane attack complex (MAC) of complement were detected by immunofluorescence microscopy on the surface of cytotoxic lymphocytes during the antibody-dependent cellular cytotoxicity (ADCC) reaction. This study employed antibody-sensitized chicken erythrocytes as target cells, human peripheral blood lymphocytes as effector cells, and RITC-conjugated rabbit F(ab')2-anti-neoAg. NeoAg was present on 60% of ADCC plaque-forming lymphocytes (PFL). Eight out of 182 neoAg-positive PFL were observed in direct contact with their target cells. In these cases MAC-specific neoAg was visualized at the zone of contact between the cells. Anti-neoAg Ig was found to inhibit ADCC plaque assays up to 62%; and 51Cr-release assays up to 79%. Stimulation of lymphocytes by PHA or mixed lymphocyte culture increased the expression of neoAg. In the case of PHA, increased neoAg expression was correlated with an increased incorporation of 14C-leucine into C5, C6, C7, and C8 antigens, which was detected by immunodiffusion and autoradiography.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Are complement lysis and lymphocytotoxicity analogous?

Authors:  P J Lachmann
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

Review 3.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.

Authors:  R H Ward; P J Lachmann
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

5.  Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity.

Authors:  R R Dourmashkin; P Deteix; C B Simone; P Henkart
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

6.  The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.

Authors:  P Woo; P J Lachmann
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

7.  Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8.

Authors:  J Tschopp; E R Podack; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  High activity of N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in-vivo-induced cytotoxic effector cells.

Authors:  G Dennert; C G Anderson; G Prochazka
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.